Implantable pulse generator market hots up in the US
This article was originally published in Clinica
Executive Summary
Advanced Neuromodulation Systems (ANS) looks set to end what it claims is Medtronic's stranglehold of the implantable pulse generator (IPG) market in the US, after gaining FDA approval for its own IPG product.